Yüklüyor......
Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease
BACKGROUND: Iron isomaltoside 1000 is a novel injectable iron compound which offers potential advantages in the treatment of subjects with iron-deficiency anemia. We studied the pharmacokinetics (PK) of this novel compound in subjects with mild-to-moderate inflammatory bowel disease (IBD). METHODS:...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3299547/ https://ncbi.nlm.nih.gov/pubmed/22419860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S30015 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|